Cargando…

Patient-Derived Induced Pluripotent Stem Cell-Based Models in Parkinson’s Disease for Drug Identification

Parkinson’s disease (PD) is a common progressive neurodegenerative disorder characterized by loss of striatal-projecting dopaminergic neurons of the ventral forebrain, resulting in motor and cognitive deficits. Despite extensive efforts in understanding PD pathogenesis, no disease-modifying drugs ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kouroupi, Georgia, Antoniou, Nasia, Prodromidou, Kanella, Taoufik, Era, Matsas, Rebecca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582359/ https://www.ncbi.nlm.nih.gov/pubmed/32993172 http://dx.doi.org/10.3390/ijms21197113

Ejemplares similares

High content screening and proteomic analysis identify a kinase inhibitor that rescues pathological phenotypes in a patient-derived model of Parkinson’s disease
por: Antoniou, Nasia, et al.
Publicado: (2022)

Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models
por: Taoufik, Era, et al.
Publicado: (2018)

Early Signs of Molecular Defects in iPSC-Derived Neural Stems Cells from Patients with Familial Parkinson’s Disease
por: Akrioti, Elissavet, et al.
Publicado: (2022)

MicroRNA-934 is a novel primate-specific small non-coding RNA with neurogenic function during early development
por: Prodromidou, Kanella, et al.
Publicado: (2020)

Species-Specific miRNAs in Human Brain Development and Disease
por: Prodromidou, Kanella, et al.
Publicado: (2019)

Long Non-coding RNAs Associated With Neurodegeneration-Linked Genes Are Reduced in Parkinson’s Disease Patients
por: Elkouris, Maximilianos, et al.
Publicado: (2019)

CEND1 and NEUROGENIN2 Reprogram Mouse Astrocytes and Embryonic Fibroblasts to Induced Neural Precursors and Differentiated Neurons
por: Aravantinou-Fatorou, Katerina, et al.
Publicado: (2015)

Prox1 Regulates the Notch1-Mediated Inhibition of Neurogenesis
por: Kaltezioti, Valeria, et al.
Publicado: (2010)

Modeling Parkinson’s Disease Using Induced Pluripotent Stem Cells
por: Byers, Blake, et al.
Publicado: (2012)

The Progress of Induced Pluripotent Stem Cells as Models of Parkinson's Disease
por: Kang, Ji-feng, et al.
Publicado: (2016)

Using induced pluripotent stem cells for modeling Parkinson’s disease
por: Ke, Minjing, et al.
Publicado: (2019)

Modeling Parkinson's Disease Using Induced Pluripotent Stem Cells
por: Hu, Xinchao, et al.
Publicado: (2020)

Transgene Reactivation in Induced Pluripotent Stem Cell Derivatives and Reversion to Pluripotency of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells
por: Galat, Vasiliy, et al.
Publicado: (2016)

Early Transcriptional Changes in Rabies Virus-Infected Neurons and Their Impact on Neuronal Functions
por: Kim, Seonhee, et al.
Publicado: (2021)

Identification of stable housekeeping genes for induced pluripotent stem cells and -derived endothelial cells for drug testing
por: Ong, Sheena L. M., et al.
Publicado: (2022)

Patient-Derived Induced Pluripotent Stem Cells and Organoids for Modeling Alpha Synuclein Propagation in Parkinson's Disease
por: Koh, Yong Hui, et al.
Publicado: (2018)

Generation of induced Pluripotent Stem Cells as disease modelling of NLSDM
por: Tavian, D., et al.
Publicado: (2017)

Induced pluripotent stem cells for modeling and cell therapy of Parkinson's disease
por: Csöbönyeiová, Mária, et al.
Publicado: (2016)

Induced pluripotent stem cell-derived cardiomyocytes for cardiovascular disease modeling and drug screening
por: Sharma, Arun, et al.
Publicado: (2013)

Induced Pluripotent Stem Cells for Treatment of Alzheimer’s and Parkinson’s Diseases
por: Yefroyev, David A, et al.
Publicado: (2022)

Cell therapy for Parkinson’s disease with induced pluripotent stem cells
por: Morizane, Asuka
Publicado: (2023)

Derivation and Identification of Motor Neurons from Human Urine-Derived Induced Pluripotent Stem Cells
por: Yi, Huan, et al.
Publicado: (2018)

Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson’s disease
por: Doi, Daisuke, et al.
Publicado: (2020)

Pharmacological intervention in a transgenic mouse model improves Alzheimer’s-associated pathological phenotype: Involvement of proteasome activation
por: Djordjevic, Aleksandra N. Mladenovic, et al.
Publicado: (2020)

Modeling Parkinson’s Disease Using Patient-specific Induced Pluripotent Stem Cells
por: Li, Hong, et al.
Publicado: (2018)

Targeting α-Synuclein in Parkinson's Disease by Induced Pluripotent Stem Cell Models
por: Spathopoulou, Angeliki, et al.
Publicado: (2022)

Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation
por: Sampaziotis, Fotios, et al.
Publicado: (2015)

Pluripotent stem cell derived dopaminergic subpopulations model the selective neuron degeneration in Parkinson’s disease
por: Oosterveen, Tony, et al.
Publicado: (2021)

Drug Development and the Use of Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Disease Modeling and Drug Toxicity Screening
por: Ovics, Paz, et al.
Publicado: (2020)

Current State-of-the-Art and Unresolved Problems in Using Human Induced Pluripotent Stem Cell-Derived Dopamine Neurons for Parkinson’s Disease Drug Development
por: Antonov, S. A., et al.
Publicado: (2021)

Pathophysiological Investigation of Skeletal Deformities of Musculocontractural Ehlers–Danlos Syndrome Using Induced Pluripotent Stem Cells
por: Yue, Fengming, et al.
Publicado: (2023)

Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges
por: Xiao, Bin, et al.
Publicado: (2016)

Phenotypic Drug Screening for Dysferlinopathy Using Patient‐Derived Induced Pluripotent Stem Cells
por: Kokubu, Yuko, et al.
Publicado: (2019)

Human Pluripotent Stem Cell-Derived Cardiomyocytes for Assessment of Anticancer Drug-Induced Cardiotoxicity
por: Schwach, Verena, et al.
Publicado: (2020)

Modeling Parkinson’s Disease and Atypical Parkinsonian Syndromes Using Induced Pluripotent Stem Cells
por: Mishima, Takayasu, et al.
Publicado: (2018)

Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson’s Disease
por: Kim, Jeffrey, et al.
Publicado: (2022)

Current Status and Challenges of Human Induced Pluripotent Stem Cell-Derived Liver Models in Drug Discovery
por: Tricot, Tine, et al.
Publicado: (2022)

Identification and Purification of Human Induced Pluripotent Stem Cell-Derived Atrial-Like Cardiomyocytes Based on Sarcolipin Expression
por: Josowitz, Rebecca, et al.
Publicado: (2014)

Taurine rescues mitochondria-related metabolic impairments in the patient-derived induced pluripotent stem cells and epithelial-mesenchymal transition in the retinal pigment epithelium
por: Homma, Kohei, et al.
Publicado: (2021)

Dental applications of induced pluripotent stem cells and their derivatives()
por: Gao, Pan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9nqh935c7eqrq9p14121l0gm7t